- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 5.39M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $26K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $20M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $20M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.47B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.46B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.63B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.62B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 5.38M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $31K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $3.17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $152.58M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $153.04M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.68 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.68 |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.65M |